logo

For the Inventor, By the Inventor

Vienna, Austria

Dieter Binder

USPTO Granted Patents = 35


Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 247(Granted Patents)


Location History:

  • Vienna, OE (1978)
  • Wien, AT (1990 - 1994)
  • Vienna, AT (1979 - 2012)

Company Filing History:

goldMedal11 out of 4,945 
 
Hoffmann-la Roche Inc.
 patents
silverMedal6 out of 6 
 
Chemisch Pharmazeutische Forschungsgesellschaft M.b.h.
 patents
bronzeMedal3 out of 4 
 
Laevosan-gesellschaft Mbh & Co Kg
 patents
4. 3 out of 11 
 
Cl Pharma Aktiengesellschaft
 patents
5. 2 out of 69 
 
Chemie Linz Aktiengesellschaft
 patents
6. 2 out of 6 
 
Laevosan-gesellschaft M.b.h.
 patents
7. 1 out of 1 
 
Chemisch Pharmazeutische Forschungsgesellschaft
 patent
8. 1 out of 1 
 
Leavoson-gesellschaft M.b.h. & Co. Kg
 patent
9. 1 out of 1 
 
Chemish Pharmazeutische Forschungsgesellschaft M.b.h.
 patent
10. 1 out of 1 
 
Ebewe Arzneimittel Gesellschaft M.b.h.
 patent
11. 1 out of 13 
 
Dritte Patentportfolio Beteiligungsgesellschaft Mbh &co. Kg
 patents
12. 1 out of 1 
 
Chemie Linz Akteingesellschaft
 patent
13. 1 out of 1 
 
Chemie-linz Aktiengesellschaet
 patent
14. 1 out of 1 
 
Chemi Linz Aktiengesellschaft
 patent

Years Active: 1978-2012

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents
1. 8129370 - Use of oxicam compounds (2012-03-06),
2. 5679678 - Thienithiazine derivatives (1997-10-21),
3. 5527796 - Thienothiazine derivatives and their use (1996-06-18),
4. 5352692 - Thiophene-2-carboxylic acid derivatives (1994-10-04),
5. 5298519 - Acylals of imidazole-5-carboxylic acid derivatives, and their use as (1994-03-29),
6. 5254574 - New tetrazole derivatives, process for their preparation and their use (1993-10-19),
7. 5100911 - Thienyloxyalkylamine derivatives, process for their preparation and (1992-03-31),
8. 5086180 - Sulphamoylthiophenes, a process for their preparation (1992-02-04),
9. 5077307 - Thienopyran derivatives, their use for treating hypertension and asthma (1991-12-31),
10. 4994484 - 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl)-3-phenyl-1-propanones (1991-02-19),
11. 4978671 - Thieno (3',4'-4,5)imidazo(2,1-b)thiazole derivatives, a process for (1990-12-18),
12. 4929616 - Novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxides, (1990-05-29),
13. 4927821 - Enol ethers of (1990-05-22),
14. 4877809 - Novel 2-thienyloxyacetic acid derivatives, a process for their (1989-10-31),
15. 4841065 - Isoxazole derivatives with antiviral activities and pharmaceutical (1989-06-20),

Title: Innovations in Medical Treatments: The Patents of Dieter Binder

Introduction: Dieter Binder, an accomplished inventor based in Vienna, Austria, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 35 patents. His work focuses on innovative compounds and treatments that aim to address critical medical conditions, including Alzheimer's disease and inflammation.

Latest Patents: Among Binder's latest inventions are methods that utilize oxicam compounds, specifically lornoxicam or its analogues. This invention addresses the inhibition of cyclo-oxygenase 1 and cyclo-oxygenase 2 (COX-1 and COX-2) while not being able to penetrate the blood-brain barrier under physiological conditions. It is designed to reduce the prostaglandin E2-induced induction of the amyloid-precursor-protein (APP), paving the way for potential pharmaceutical compositions aimed at treating or preventing Alzheimer's disease and arteriosclerosis. Another notable patent involves thienothiazine derivatives, which are valuable for managing inflammation and pain, showcasing Binder's dedication to enhancing patient care through his innovative approaches.

Career Highlights: Dieter Binder's illustrious career includes significant tenures at notable companies such as Hoffmann-La Roche Inc. and Chemisch Pharmazeutische Forschungsgesellschaft M.b.h. His extensive experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations: Throughout his career, Binder has collaborated with distinguished colleagues, including Otto Hromatka and Franz Rovenszky. These partnerships have fostered knowledge exchange and innovation, further enhancing the impact of his work on medical science.

Conclusion: Dieter Binder remains a pivotal figure in the realm of pharmaceutical innovations. His extensive patent portfolio reflects his commitment to advancing medicine, particularly in the treatment of serious health conditions. Through his groundbreaking inventions, Binder continues to inspire future generations of inventors and researchers in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…